STING1 and neoplasm: Importantly, in this paradigm, the DRGs from tumor-bearing mice retain their hyperexcitable state relative to DRGs from naïve mice, enabling us to test whether DMXAA-mediated STING activation in DRGs can directly reduce nociceptor excitability.